Click here to join our community

23 Default
25 Default
27 Default
29 Default
31 Default
33 Default
35 Default

Site Map

© 2017 PuraCap® Pharmaceutical LLC
All Rights Reserved.

This site is only intended for residents of the United States. The products discussed on this website may have different labeling in different countries

PuraCap® Pharmaceutical LLC,
Piscataway, NJ 08854.

U.S.A.
Phone: 908.941.5456
Fax: 908.941.5457

Leadership Team

173 Default
175 Default
179 Default
181 Default
183 Default

Xiaofeng Meng, PhD

VP of Quality & Regulatory Affair

As VP of Quality & Regulatory Affair, Dr. Meng ensures compliance with all regulations and laws pertaining to the development and manufacturing of PuraCap products.

Dr. Meng has more than 15 years of pharmaceutical research and development, manufacturing and regulatory experience – including extensive experience formulating and executing regulatory strategies for proprietary and generic drug products and comprehensive knowledge of cGMP/GLP (current Good Manufacturing Practices/Good Labor Practices) compliance and quality systems.

As Director of Chemistry, Manufacturing and Controls (CMC) Management for Hurley Consulting Associates, Ltd., he interfaced with regulatory authorities, including the U.S. FDA (Food and Drug Administration) and EMA (European Medicines Agency), on behalf of clients throughout the drug development process, managed a CMC group, and prepared dossiers for various dosage forms, which resulted in successful submissions of multiple investigational and marketing applications for proprietary and generic drugs domestically and internationally.

As Senior Scientist II in Aerosol R&D for Abbott Laboratories, Inc. (formally Kos Pharmaceuticals, Inc.), Dr. Meng managed and supported projects leading to submissions of an Investigational New Drug for a proprietary and New Drug Application Supplements for a marketed asthma product.

Dr. Meng was also a Research Assistant at the Laboratory for Cancer Research at Rutgers University, where he authored many publications on cancer prevention and co-developed several analytical methods for tea catechins, which have been adopted for laboratories worldwide. He received the Gallo Award from the Cancer Institute of New Jersey in 1999, and the Award for Excellence in Graduate Research in Food Chemistry at the 2002 ACS National Meeting.

Dr. Meng’s academic degrees include: a Master’s in Business Administration from Rutgers University in New Jersey, a PhD in Food Science from Rutgers, and a Master’s degree in Pharmaceutical Science from the Shanghai Institute of the Pharmaceutical Industry, Shanghai, P.R. China.

He is a member of the American Association of Pharmaceutical Scientists (AAPS) and the American Chemical Society (ACS).

Manufacturing A World of Wellness

Global expertise in product development; producing quality, affordable pharmaceutical and healthcare products.

Click here to join our community

homeHOME

AS

All PuraCap Pharmaceutical prescription
brand products meet our rigorous standards
for quality, accessibility and ease of therapeutic delivery.

PuraCap Laboratories develops & markets prescription generic medications to meet patient needs for quality, efficacy and affordable products.

Our over the counter (OTC) business, Puravation Pharmaceuticals provides many top quality, OTC store brand &
private label products.

With our turn-key services, we can develop Prescription and OTC soft gelatin capsules in our state of the art facility, designed and constructed in accordance with all US FDA cGMP regulatory guidances.

November 16, 2015

South Plainfield, NJ– November 3, 2015 – PuraCap Pharmaceutical LLC
announced today the introduction of a
new product, EpiCeram-L™ Lip Care,
a unique lip care formulation with an
exclusive delivery

July 10, 2014

PuraCap™ Pharmaceutical Introduces
Unique EpiCeram® 225g Airless Pump
EpiCeram® Controlled Release Skin
Barrier Emulsion Now Offers Dosing
Flexibility with 2 Sizes.

November 13, 2015

South Plainfield, NJ–November 11, 2015 – PuraCap Pharmaceutical LLC. is pleased to announce that the US Food and Drug Administration (FDA) has completed a successful inspection of its affiliated

May 19, 2014

Max Baucus, US Ambassador to China visits Wuhan Softgel Capsule Manufacturing Plant in Wuhan China
SOUTH PLAINFIELD, N.J., May 19, 2014 /PRNewswire/ — PuraCap Pharmaceutical today announced

Site Map

© 2017 PuraCap® Pharmaceutical LLC
All Rights Reserved.

This site is only intended for residents of the United States. The products discussed on this website may have different labeling in different countries

PuraCap® Pharmaceutical LLC,
Piscataway, NJ 08854.

U.S.A.
Phone: 908.941.5456
Fax: 908.941.5457

Leadership Team

EpiCeram® is a leading prescription product that has the ability to help repair and heal the skin barrier through a unique mode-of-action different from other medications and eczema treatments. Typically, EpiCeram® is prescribed along with a topical steroid product, but EpiCeram® can also be prescribed alone. Only EpiCeram® contains the skin’s natural level of 3 essential lipids, such as ceramides, cholesterol and free fatty acids, which are reduced in patients with eczema or atopic dermatitis. EpiCeram® is steroid-free, fragrance-free, noncomedogenic1 , paraben-free, and propylene glycol-free.

EpiCeram-L™ Lip Care is the first of its kind, using a patented MultiSal™ Technology an exclusive multi-component controlled-release of important lipids, creating a moist, luxuriant feel.
EpiCeram-L™ Lip Care contains 3 essential lipids ceramides, conjugated linoleic acid (CLA) and cholesterol.
EpiCeram-L™ Lip Care is steroid-free, paraben-free, gluten-free, petrolatum-free, fragrance-free, color-free, and aloe rich to soothe lips on contact. It is ideal for the most severe, dry, cracked lips.

This is a Text / HTML area, click this box to edit text or to past HTML, do not paste Word document selections into me or other programs that are not plain text or HTML. If you need to post text from another program, open a simple notepad program and paste the text in notepad and then re-copy the text.

PuraCap offers full service contract manufacturing services for your products. From concept to commercilazation, we can provide you with full turn-key commercial development services.

With full capabilities to develop Monographed OTC’s, ANDA’s, 505(b) (1) and 505(b) (2), we can provide quaility, reliablity and cost effective manufacturing and development services. Our R & D teams in New Jersey & Wuhan, China will work with you every step of the way, to bring your current or future project to full commercializaton.

Our state of the art 140,000 sq ft soft gel facility in Wuhan China meets all cGMP FDA regulatory requirements for pharmaceutical (Rx & OTC’s) development and manufacturing. With capacity of up the 4 billion soft gel capsules annually we have the ability to meet your needs. For more information please contact us at bd@puracap.com

A wide range of PuraCap products are manufactured by our affiliated manufacturing partner, Humanwell Puracap Pharmaceuticals (Wuhan) Co., Ltd, a US FDA cGMP compliant facility that complies with international regulatory standards. Our goal is to put quality first, by building quality through design and a commitment to the highest standards. We strive to exceed USFDA, cGMP standards to assure our customers the quality product they expect.

The experienced manufacturing team, led by a well-recognized technical manufacturing authority in the soft gelatin pharmaceutical capsule industry, is committed to growing our business responsibly – utilizing proven and innovative processes and procedures to produce quality products without compromise. The manufacturing team is backed by a U.S. executive team with decades of experience in FDA (Federal Drug Administration) regulated prescription drug cGMP quality system management and process validation.

The Manufacturing team strives to provide cost-efficiency through manufacture at state-of-the art facilities built to USFDA specifications. Our model for success is to make use of labor as well as manufacturing efficiencies while meeting the highest quality standards. This model sets us apart from the competition. Our customers can be confident in our products—-highest quality at a competitive price.

Dahai Guo has a proven, successful track record of senior management experience with multi-billion-dollar healthcare and pharmaceutical companies including Hoffmann-La Roche, Inc., Inverness Medical, Inc., Ansell Healthcare (formally Pacific Dunlop Group) and Invitrogen. Mr. Guo specializes in global strategic planning, sales, marketing, product development and launching new brands for the healthcare product industry. He has successful experience in founding and growing start-up companies that later became listed on the NASDAQ. Mr. Guo has successfully marketed more than 2,000 Over the Counter and prescription products in over 90 different countries, including the United States, the European Union, China, Australia and several South American countries. Mr. Guo has a Master of Science degree in Biology from Rutgers University in New Jersey, and a Master of Business Administration degree in General Management from Cornell University in New York. He was trained to be a Six-Sigma Black Belt by the America Society for Quality.

Xiaofeng Meng, PhD

VP of Quality & Regulatory Affair

As VP of Quality & Regulatory Affair, Dr. Meng ensures compliance with all regulations and laws pertaining to the development and manufacturing of PuraCap products.

Dr. Meng has more than 15 years of pharmaceutical research and development, manufacturing and regulatory experience – including extensive experience formulating and executing regulatory strategies for proprietary and generic drug products and comprehensive knowledge of cGMP/GLP (current Good Manufacturing Practices/Good Labor Practices) compliance and quality systems.

As Director of Chemistry, Manufacturing and Controls (CMC) Management for Hurley Consulting Associates, Ltd., he interfaced with regulatory authorities, including the U.S. FDA (Food and Drug Administration) and EMA (European Medicines Agency), on behalf of clients throughout the drug development process, managed a CMC group, and prepared dossiers for various dosage forms, which resulted in successful submissions of multiple investigational and marketing applications for proprietary and generic drugs domestically and internationally.

As Senior Scientist II in Aerosol R&D for Abbott Laboratories, Inc. (formally Kos Pharmaceuticals, Inc.), Dr. Meng managed and supported projects leading to submissions of an Investigational New Drug for a proprietary and New Drug Application Supplements for a marketed asthma product.

Dr. Meng was also a Research Assistant at the Laboratory for Cancer Research at Rutgers University, where he authored many publications on cancer prevention and co-developed several analytical methods for tea catechins, which have been adopted for laboratories worldwide. He received the Gallo Award from the Cancer Institute of New Jersey in 1999, and the Award for Excellence in Graduate Research in Food Chemistry at the 2002 ACS National Meeting.

Dr. Meng’s academic degrees include: a Master’s in Business Administration from Rutgers University in New Jersey, a PhD in Food Science from Rutgers, and a Master’s degree in Pharmaceutical Science from the Shanghai Institute of the Pharmaceutical Industry, Shanghai, P.R. China.

He is a member of the American Association of Pharmaceutical Scientists (AAPS) and the American Chemical Society (ACS).